We are monitoring the impact of COVID-19 on MEA Antiviral Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1513
Share on
Share on

Middle East & Africa Antiviral Drugs Market Research Report - Segmented By Application, Target, End Users & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1513
Pages: 142

MEA Antiviral Drugs Market Size (2021 to 2026)

As per our research report, the Middle East & Africa Antiviral Drugs Market size is estimated to be worth USD 3.03 billion by 2026 and USD 2.36 billion in 2021, growing at a CAGR of 5.07% during the forecast period.

The governments of MEA countries and other non-profit organizations have launched awareness programs on available treatments for sexually transmitted diseases. With the increasing adoption of antiviral drugs, the MEA antiviral drugs market is expected to witness dramatic growth over the forecast period.

Viral infections are one of the major diseases affecting millions of lives around the world. Significant efforts were made in the development of antiviral drugs in the recent past by research institutes and biopharmaceutical and pharmaceutical companies. According to the Joint United Nations Programs on HIV and AIDS, approximately 27.5 million HIV-infected patients had access to antiretroviral therapy by the end of 2020. As the number of patients increases, the market is expected to grow at a lucrative growth rate over the forecast period.

The incidence of infectious viruses such as swine flu, Ebola, Zika virus, and coronavirus has created a demand for effective antiviral therapies. The emergence of the COVID-19 pandemic, causing death and morbidity worldwide, will provide immense opportunities for research and development in the industry. Remdesivir is another clinically proven promising treatment for infections that have been tested in a few patients. With the increasing demand for antiviral drug therapy for coronavirus infections, the segment will grow significantly during the forecast period.

The growth of the MEA antiviral drugs market is expected to be hampered by the high costs involved in drug development, threats associated with counterfeit drugs, and strict government regulations. Some notable trends may include the accelerating rate of growth of infectious diseases, an increased focus on telehealth, the growth of pharmaceutical mergers and acquisitions, and the emergence of new infectious diseases.

This research report on the MEA antiviral drugs market has been segmented and sub-segmented into the following categories:

By Application: 

  • HIV/AIDS
  • Hepatitis
  • Herpes
  • Influenza
  • Others

By Target: 

  • DNA Polymerase
  • NS3 Protease
  • Reverse Transcriptase
  • Others

By End Users: 

  • Hospitals
  • Research Institutes
  • Laboratory Centers

By Country: 

  • KSA
  • UAE
  • Israel
  • Rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Regional Analysis:

The Middle East region dominated the Middle East & Africa market with over 39% share in 2020. This is attributed to the presence of key features in the region, such as the availability of infrastructure, sophisticated healthcare, and increased awareness of viral diseases. Increasing patient base, improving the economic stability, and the presence of strong and established generic drug market in Gulf countries are some of the key factors that are expected to provide growth opportunities for the market from the Middle East and African regions.

The sudden outbreak of COVID-19 has caused a major disruption worldwide, which is generating massive demand for antiviral drugs for the treatment of patients infected with the coronavirus, providing a growth opportunity for the global market.

KEY MARKET PLAYERS:

Some of the promising companies operating in the MEA antiviral drugs market profiled in the report are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 HIV/AIDS

                                5.1.3 Hepatitis  

                                5.1.4 Herpes     

                                5.1.5 Influenza 

                                5.1.6 Others      

                                5.1.7 Y-o-Y Growth Analysis, By Application         

                                5.1.8 Market Attractiveness Analysis, By Application        

                                5.1.9 Market Share Analysis, By Application         

                5.2 Target                           

                                5.2.1 Introduction           

                                5.2.2 DNA polymerase  

                                5.2.3 NS3 Protease         

                                5.2.4 Reverse transcriptase        

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By Target   

                                5.2.7 Market Attractiveness Analysis, By Target

                                5.2.8 Market Share Analysis, By Target   

                5.3 End Users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals/Clinics   

                                5.3.3 Research Institutes             

                                5.3.4 Laboratory Centers             

                                5.3.5 Y-o-Y Growth Analysis, By End Users            

                                5.3.6 Market Attractiveness Analysis, By End Users          

                                5.3.7 Market Share Analysis, By End Users            

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Target

                                                6.1.3.4 By End-Users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Target

                                                6.1.4.4 By End-Users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Target

                                                6.1.5.4 By End-Users

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Johnson & Johnson                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Novartis International AG                     

                8.3 Roche Holding AG                   

                8.4 Pfizer                            

                8.5 Merck and Co. Inc                    

                8.6 GlaxoSmithKline plc                

                8.7 AstraZeneca AB                        

                8.8 Gilead Sciences                         

                8.9 Abbott Laboratories               

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  2. Middle East & Africa HIV/AIDS  Market By Region, From 2021 to 2026 ( USD Billion )
  3. Middle East & Africa Hepatitis Market By Region, From 2021 to 2026 ( USD Billion )
  4. Middle East & Africa Herpes Market By Region, From 2021 to 2026 ( USD Billion )
  5. Middle East & Africa Influenza Market By Region, From 2021 to 2026 ( USD Billion )
  6. Middle East & Africa Others Market By Region, From 2021 to 2026 ( USD Billion )
  7. Middle East & Africa Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  8. Middle East & Africa DNA polymerase Market By Region, From 2021 to 2026 ( USD Billion )
  9. Middle East & Africa NS3 Protease Market By Region, From 2021 to 2026 ( USD Billion )
  10. Middle East & Africa Reverse transcriptase Market By Region, From 2021 to 2026 ( USD Billion )
  11. Middle East & Africa Others Market By Region, From 2021 to 2026 ( USD Billion )
  12. Middle East & Africa Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )
  13. Middle East & Africa Hospitals/Clinics Market By Region, From 2021 to 2026 ( USD Billion )
  14. Middle East & Africa Research Institutes Market By Region, From 2021 to 2026 ( USD Billion )
  15. Middle East & Africa Laboratory Centers Market By Region, From 2021 to 2026 ( USD Billion )
  16. Middle East Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  17. Middle East Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  18. Middle East Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )
  19. Africa Antiviral Drugs Market By Application, From 2021 to 2026 ( USD Billion )
  20. Africa Antiviral Drugs Market By Target, From 2021 to 2026 ( USD Billion )
  21. Africa Antiviral Drugs Market By End User, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample